Research Topics
| Mitchell E GeffnerSummaryAffiliation: University of Southern California Country: USA Publications
| Collaborators
|
Detail Information
Publications
The 88th Annual Meeting of the Endocrine Society, June 24-27, 2006, Boston MA, USA: selected pediatric presentationsMitchell E Geffner
The Saban Research Institute of Childrens Hospital, Los Angeles, CA, USA
Pediatr Endocrinol Rev 5:789-95. 2008
Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort studyMitchell E Geffner
Saban Research Institute, Children s Hospital Los Angeles, Los Angeles, Calif, USA
Horm Res Paediatr 76:386-91. 2011....- For debate: Aromatase inhibitors to augment height: have we lost our inhibitions?Mitchell E Geffner
USC Keck School of Medicine, Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA
Pediatr Endocrinol Rev 5:756-9. 2008 - Use of recombinant human growth hormone in children with thalassemiaMitchell E Geffner
Saban Research Institute, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, Calif, USA
Horm Res 71:46-50. 2009..Growth failure occurs in children with chronic anemias and, in particular, in approximately 30% of those with thalassemia... 
Growth hormone replacement therapy: transition from adolescence to adulthoodMitchell E Geffner
Saban Research Institute, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, USA
J Clin Res Pediatr Endocrinol 1:205-8. 2009....- Transition to the adult endocrine clinic: testing pituitary function - what tests and when?Mitchell E Geffner
Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, 4650 Sunset Blvd, Mailstop 61, Los Angeles, CA 90027, USA
Growth Horm IGF Res 13:S117-21. 2003.... - Aromatase inhibitors to augment height: continued caution and study requiredMitchell E Geffner
Saban Research Institute, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA
J Clin Res Pediatr Endocrinol 1:256-61. 2009..Furthermore, little is known about the short- and long-term safety of AIs in children. Thus, it is imperative that there be well-designed, long-term studies of efficacy and safety of AI use in pediatric populations... - Hypopituitarism in childhoodMitchell E Geffner
Division of Endocrinology, Childrens Hospital Los Angeles, California 90027, USA
Cancer Control 9:212-22. 2002..Childhood hypopituitarism may be present at birth or may be acquired. Early diagnosis and treatment promote the best possible outcomes... - Future directions: growth prediction modelsMitchell E Geffner
Saban Research Institute, Childrens Hospital Los Angeles, Los Angeles, Calif, USA
Horm Res 68:51-6. 2007.... - Serum prolactin concentrations in relation to hypopituitarism and obesity in children with optic nerve hypoplasiaAmy M Vedin
Center for Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Keck School of Medicine of USC and Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
Horm Res Paediatr 77:277-80. 2012.... - Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short childrenPinchas Cohen
Pediatric Endocrinology, Mattel Children s Hospital at University of California, Los Angeles, 10833 Le Conte Avenue, MDCC 22 315, Los Angeles, California 90095, USA
J Clin Endocrinol Metab 95:2089-98. 2010..We recently showed that, in IGF-based GH therapy, the IGF-I target chosen affects GH dose requirements, and higher IGF-I targets are associated with more robust growth parameters... - Newborn thyroid-stimulating hormone in children with optic nerve hypoplasia: associations with hypothyroidism and visionCassandra Fink
The Vision Center, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
J AAPOS 16:418-23. 2012.... - Evolving central hypothyroidism in children with optic nerve hypoplasiaNina S Ma
Division of Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Childrens Hospital Los Angeles and Keck School of Medicine of the University of Southern California, USA
J Pediatr Endocrinol Metab 23:53-8. 2010..Children with optic nerve hypoplasia (ONH) are at high risk for early-onset congenital central hypothyroidism (CH); however, reports of evolving, late-onset CH are rare and poorly documented... - Optic nerve hypoplasia in North America: a re-appraisal of perinatal risk factorsPamela Garcia-Filion
The Vision Center at Childrens Hospital Los Angeles, and Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California 90027, USA
Acta Ophthalmol 88:527-34. 2010..The purpose of this study is to describe and clarify the birth and prenatal characteristics of a large cohort of children with optic nerve hypoplasia... - Obese adolescents show impaired meal responses of the appetite-regulating hormones ghrelin and PYYSteven D Mittelman
Division of Endocrinology, Diabetes and Metabolism, Children s Hospital Los Angeles, Los Angeles, California, USA
Obesity (Silver Spring) 18:918-25. 2010..Thus, meal-related changes in active ghrelin and PYY are blunted in obese as compared to lean Hispanic subjects. This blunting could contribute to the development or worsening of obesity... - Rathke's cleft cyst in two girls with precocious pubertyRoshanak Monzavi
Division of Endocrinology, Diabetes, and Metabolism, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
J Pediatr Endocrinol Metab 17:781-5. 2004..We report here two patients, both of whom presented with precocious puberty, and were found to have Rathke's cleft cysts... - Hereditary vitamin D resistant rickets: identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapyNina S Ma
Division of Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Childrens Hospital Los Angeles and Keck School of Medicine of the University of Southern California, Los Angeles, CA 90027, USA
Bone 45:743-6. 2009.... - Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasiaAmy M Vedin
Center for Endocrinology, Diabetes, and Metabolism, Children s Hospital Los Angeles, 4650 Sunset Boulevard, Mailstop 61, Los Angeles, CA 90027, USA
Int J Pediatr Endocrinol 2011:17. 2011..abstract:.. - Neuroradiographic, endocrinologic, and ophthalmic correlates of adverse developmental outcomes in children with optic nerve hypoplasia: a prospective studyPamela Garcia-Filion
Division of Pediatric Ophthalmology, Department of Ophthalmology, University of Southern California Keck School of Medicine and Childrens Hospital Los Angeles, Los Angeles, California, USA
Pediatrics 121:e653-9. 2008.... - A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormoneSteven D Mittelman
Division of Endocrinology, Diabetes, and Metabolism, Childrens Hospital Los Angeles, 4650 Sunset Boulevard, Mail Stop Number 61, Los Angeles, California 90027, USA
J Clin Endocrinol Metab 91:2474-9. 2006..Treatment with replacement PTH may be warranted, although this has yet to be evaluated in children... - Obesity and fat quantification in lean tissues using three-point Dixon MR imagingArzu Kovanlikaya
Department of Radiology, Children's Hospital of Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA
Pediatr Radiol 35:601-7. 2005..74; P=0.001). SUMMARY: We conclude that in nondiabetic teenagers, obesity is associated with an increased accumulation of fat in the pancreas without impairment of insulin secretion... - Igf-I stimulates in vivo thymopoiesis after stem cell transplantation in a child with Omenn syndromeNina S Ma
Division of Endocrinology, Diabetes, and Metabolism, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
J Clin Immunol 30:114-20. 2010..Children with severe combined immunodeficiency who receive a T cell-depleted hematopoietic stem cell transplantation (HSCT) have delayed immune reconstitution... - Gynecomastia in prepubertal and pubertal menNina S Ma
Division of Endocrinology, Diabetes, and Metabolism, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
Curr Opin Pediatr 20:465-70. 2008..Understanding its pathogenesis is crucial to distinguish a normal developmental variant from pathological causes... - Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle interventionRoshanak Monzavi
Center for Diabetes, Endocrinology, and Metabolism, Los Angeles, California, USA
Pediatrics 117:e1111-8. 2006.... - Craniopharyngioma in childhoodJoshua A May
Division of Endocrinology, Diabetes, and Metabolism, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, 4650 Sunset Boulevard, MS 61, Los Angeles, CA 90027, USA
Adv Pediatr 53:183-209. 2006.... - Simultaneous development of pheochromocytomas in prepubertal siblings with von Hippel-Lindau syndromeSherry Lynn Franklin
Division of Endocrinology, Department of Pediatrics, Mattel Children's Hospital at UCLA, Los Angeles, California 90095, USA
J Pediatr 140:625-8. 2002..We report 2 siblings with a known von Hippel-Lindau mutation who simultaneously developed asymptomatic pheochromocytomas at significantly younger ages than are typically seen in this setting... - Precocious puberty secondary to topical testosterone exposureSherry Lynn Franklin
Mattel Children's Hospital at UCLA, Los Angeles, CA, USA
J Pediatr Endocrinol Metab 16:107-10. 2003..67 year-old boy resulting from presumed inadvertent, long-term exposure to a topical testosterone cream being used by his father... - Cognitive and behavioral characteristics of turner syndrome: exploring a role for ovarian hormones in female sexual differentiationMarcia L Collaer
University of California, Los Angeles, California 90095, USA
Horm Behav 41:139-55. 2002..These results are consistent with a role for ovarian hormones acting on the brain to influence cognitive and behavioral development, although they do not rule out other possible interpretations... - Hypothalamic-pituitary-adrenal activity among Armenian adolescents with PTSD symptomsArmen K Goenjian
Department of Psychiatry and Biobehavioral Sciences, UCLA Duke University National Center for Child Traumatic Stress, UCLA School of Medicine Los Angles, California 90064, USA
J Trauma Stress 16:319-23. 2003..The pre- to postexercise increase in GH, TSH, and cortisol suggests that exercise challenge may be useful in the field investigation of neurohormonal activity among traumatized individuals... - Growth hormone treatment in children with familial dysautonomiaManmohan K Kamboj
Department of Pediatrics, New York University Medical Center, New York, New York 10016, USA
J Pediatr 144:63-7. 2004..CONCLUSION: The data demonstrate that GH treatment in patients with FD may increase growth velocity, at least in the short term. This experiential data supports a future prospective study... - Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trialMarsha L Davenport
Division of Pediatric Endocrinology, University of North Carolina, CB 7039, 3341 Medical Biomolecular Research Building, Chapel Hill, North Carolina 27599 7039, USA
J Clin Endocrinol Metab 92:3406-16. 2007..Typically, growth failure in Turner syndrome (TS) begins prenatally, and height sd score (SDS) declines progressively from birth... - Compound heterozygosity of a frameshift mutation in the coding region and a single base substitution in the promoter of the ACTH receptor gene in a family with isolated glucocorticoid deficiencyPanayoula C Tsiotra
Hellenic National Diabetes Center, Athens, Greece
J Pediatr Endocrinol Metab 19:1157-66. 2006..In conclusion, we provide evidence that the IGD in this previously unreported family with ACTH resistance appears to be secondary to compound heterozygosity of a coding region and a promoter mutation in the MC2R gene...